Articles dans des revues avec comité de lecture (123)
  1. 16. Bisteau, X., Paternot, S., Colleoni, B., Ecker, K., Coulonval, K., De Groote, P., Declercq, W., Hengst, L., & Roger, P. P. (2013). CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point. PLOS genetics, 9(5), e1003546. doi:10.1371/journal.pgen.1003546
  2. 17. Farhang Ghahremani, M., Goossens, S., Nittner, D., Bisteau, X., Bartunkova, S., Zwolinska, A., Hulpiau, P., Haigh, K., Haenebalcke, L., Drogat, B., Jochemsen, A., Roger, P. P., Marine, J.-C., & Haigh, J. J. (2013). p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway. Cell death and differentiation. doi:10.1038/cdd.2013.12
  3. 18. Lodewick, J., Sampaio, C., Boxus, M., Rinaldi, A.-S., Coulonval, K., Willems, L., Roger, P. P., & Bex, F. (2013). Acetylation at lysine 346 controls the transforming activity of the HTLV-1 Tax oncoprotein in the Rat-1 fibroblast model. Retrovirology, 10, 75. doi:10.1186/1742-4690-10-75
  4. 19. Coulonval, K., Kooken, H., & Roger, P. P. (2011). Coupling of T161 and T14 phosphorylations protects cyclin B-CDK1 from premature activation. Molecular biology of the cell. doi:10.1091/mbc.E11-02-0136
  5. 20. Juvenal, G., Christophe, D., Roger, P. P., & Pisarev, M. A. (2011). Thyroid Function and Growth Regulation under Normal and Abnormal Conditions. Journal of Thyroid Research, 2011, 805036. doi:10.4061/2011/805036
  6. 21. Blancquaert, S., Wang, L., Paternot, S., Coulonval, K., Dumont, J. E., Harris, T. E., & Roger, P. P. (2010). cAMP-Dependent Activation of Mammalian Target of Rapamycin (mTOR) in Thyroid Cells. Implication in Mitogenesis and Activation of CDK4. Molecular endocrinology, 24(7), 1468, 1453. doi:10.1210/me.2010-0087
  7. 22. Maenhaut, C., Dumont, J. E., Roger, P. P., & van Staveren, W. C. G. (2010). Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis, 31(2), 149-158. doi:10.1093/carcin/bgp259
  8. 23. Paternot, S., Bockstaele, L., Bisteau, X., Kooken, H., Coulonval, K., & Roger, P. P. (2010). Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Cell cycle (Georgetown, Tex.), 9(4), 689-699.
  9. 24. Roger, P. P., van Staveren, W. C. G., Coulonval, K., Dumont, J. E., & Maenhaut, C. (2010). Signal transduction in the human thyrocyte and its perversion in thyroid tumors. Molecular and cellular endocrinology, 321(1), 3-19. doi:10.1016/j.mce.2009.11.015
  10. 25. Bockstaele, L., Bisteau, X., Paternot, S., & Roger, P. P. (2009). Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation. Molecular and cellular biology, 29(15), 4188-4200. doi:10.1128/MCB.01823-08
  11. 26. Hebrant, A., Van Sande, J., Roger, P. P., Patey, M., Klein, M., Bournaud, C., Savagner, F., Leclère, J., Dumont, J. E., van Staveren, W. C. G., & Maenhaut, C. (2009). Thyroid gene expression in familial nonautoimmune hyperthyroidism shows common characteristics with hyperfunctioning autonomous adenomas. The Journal of clinical endocrinology and metabolism, 94(7), 2602-2609. doi:10.1210/jc.2008-2191
  12. 27. Paternot, S., & Roger, P. P. (2009). Combined inhibition of MEK and mammalian target of rapamycin abolishes phosphorylation of cyclin-dependent kinase 4 in glioblastoma cell lines and prevents their proliferation. Cancer research, 69(11), 4577-4581. doi:10.1158/0008-5472.CAN-08-3260
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>